Re:Antibiotic Breakthrough Ends 25-Year Discovery Drought
by Fomite on Thursday January 08, 2015 @01:57PM
(#8858127)
Fidaxomycin, which was developed by Optimer Pharmaceuticals to treat C. difficle, was relatively inexpensive to run. I want to say in the vicinity of $100 million
[ Parent
| on HN ]
There are no comments on this comment yet.